Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 50 non-cytoplasmic 51 72 transmembrane 73 83 cytoplasmic 84 103 transmembrane 104 108 non-cytoplasmic 109 130 transmembrane 131 142 cytoplasmic 143 164 transmembrane 165 183 non-cytoplasmic 184 203 transmembrane 204 259 cytoplasmic 260 285 transmembrane 286 300 non-cytoplasmic 301 322 transmembrane 323 328 cytoplasmic 329 349 transmembrane 350 368 non-cytoplasmic 369 393 transmembrane 394 403 cytoplasmic 404 424 transmembrane 425 434 non-cytoplasmic 435 455 transmembrane 456 466 cytoplasmic
Input: >WP_012411593.1 NCBI__GCF_000020025.1:WP_012411593.1 MSSTTVRRKSNTFYVILIAGAAALGGFLFGFDTAVINGAVLSLAKAFNTSSWVTGLAVSL ALLGSAVGAFFAGQIADRYGRVKAMVVASVLFTISAIGSGMAFTIWDFIFWRVLGGIGIG VASVIAPAYIAECSPTHLRGRLGSLQQLAIVVGIFVALLSDYFIATSAGSADSPFLFGVA AWRWMFWTAVPPAVFYGMVALTIPESPRYLVAKGRESEAVNVLTKILGGDVLPKIEEIRQ TVLRERQPKFSDLLSRSGGLLPIVWIGIGLSVLQQFVGINVIFYYSSVLWRAVGFSEKDS LSITVITGAVNIITTLIAIAFVDKFGRKPLLIIGSIGMTLTLGTMAYIFGNAPLDAAGNP SLAGSAGTVALIAANLYVFCFGFSWGPIVWVLLGEMFNNKIRAAALSVAAAIQWVANFLI STTFPPILQYFGLGSAYGLYTIAAATSFFFILFFIKETKGIELEDM
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server